Core Wealth Advisors, Inc. Cns Pharmaceuticals, Inc. Transaction History

Core Wealth Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 04, 2021	SELL	$1.72 - $4.18 $946 - $2,299	-550 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$1.68 - $2.89 $924 - $1,589	550 New	550 $1,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Core Wealth Advisors, Inc. with notifications on news.